Dr. Mrinalini Sarkar, MD

Dr. Sarkar practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Sarkar's NPI, 1932362514, was assigned on July 3, 2008. Dr. Sarkar graduated from Government Medical College Nagpur in 2005. Dr. Sarkar holds California license C152718.

Dr. Sarkar's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Sarkar's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Sarkar is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Sarkar to 2 more hospitals and 3 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarkar practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sarkar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sarkar is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Sarkar's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acute kidney failure, aortic atherosclerois, chronic hypertension, chronic kidney disease, cirrhosis of the liver, fluid and electrolyte imbalances, heart failure and hepatitis c among the conditions Dr. Sarkar treats.

CMS data shows 704 Medicare services from Dr. Sarkar across 7 procedure codes in 2024, for 294 Medicare patients. Medicare paid $71,038 for them.

CMS counts 294 Medicare patients who saw Dr. Sarkar in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 50% are also on Medicaid. Their average risk score is 4.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarkar's median patient age at 62, with 44% women.

In 2024, Dr. Sarkar wrote 1,032 Medicare Part D claims for 170 patients. 81% of them were for generic drugs. CMS names the drug for 750 of them, across 27 drugs with 11 or more claims each, at $93,509 in total drug cost. In 2023, CMS named 1,072 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sarkar for performance year 2024, reported as part of a group. Dr. Sarkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sarkar as offering telehealth.

Dmand AI links 1 paper to Dr. Sarkar in 2025. Dr. Sarkar's most frequent co-author is Jonathan E. Zuckerman, MD, PhD.

CMS Open Payments shows 123 general payments to Dr. Sarkar from 14 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Amgen Inc. paid the most, $52,143.

Dr. Sarkar graduated from Government Medical College Nagpur in 2005. Dr. Sarkar is a member of SHM.

Dr. Sarkar is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.